FiberLocker® System for Rotator Cuff Tears
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method called the FiberLocker® System to aid in healing rotator cuff tears, which are painful shoulder injuries. Researchers aim to determine if this system enhances healing, function, and safety after surgery. Participants will undergo an MRI at least six months post-surgery to assess shoulder healing. Individuals planning surgery for a significant rotator cuff tear (at least 2 cm) and who have had an MRI within the last year may qualify for this study.
As an unphased trial, this study provides participants the chance to contribute to innovative research that could enhance future treatment options.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you have had a corticosteroid injection in the operative shoulder within three months before surgery, you would be excluded from the trial.
What prior data suggests that the FiberLocker® System is safe for rotator cuff repair?
Research shows that safety information for the FiberLocker® System, used in rotator cuff repairs, is collected from surgery through a 12-month follow-up. This system employs a special patch to aid in the repair. Studies have examined the frequency and types of side effects during this period.
MRI scans have confirmed improved healing in previous patients using this system. These scans, conducted at least six months post-surgery, assess the repair's durability. Although specific side effect numbers aren't available, ongoing testing suggests it is reasonably safe so far.
It's important to remember that while the system is designed to be safe, any surgery or medical treatment can have risks. Prospective trial participants should consult their doctor to understand what to expect.12345Why are researchers excited about this trial?
The FiberLocker® System is unique because it augments traditional rotator cuff repair, potentially enhancing the strength and durability of the repair. While standard treatments for rotator cuff tears typically involve sutures or anchors to reattach the tendon to the bone, the FiberLocker® System adds an extra layer of support. This system could improve healing outcomes and reduce the likelihood of re-tears, offering a promising option for patients with this common shoulder injury. Researchers are excited because it might lead to faster recovery times and better long-term results compared to existing methods.
What evidence suggests that the FiberLocker® System is effective for rotator cuff tears?
Research has shown that the FiberLocker® System, used in rotator cuff repairs, can enhance healing. Studies suggest that this system offers a promising approach for managing difficult rotator cuff tears, which often heal poorly. Early results indicate that the system can reduce the risk of re-tearing and improve tendon healing, as observed in MRI scans at least six months post-surgery. In this trial, all participants will have their rotator cuff tears repaired with augmentation using the FiberLocker® System. This treatment aims to support the repaired tendon, potentially improving movement and increasing patient satisfaction.12356
Are You a Good Fit for This Trial?
This trial is for individuals aged 30-70 planning to have arthroscopic surgery for a full-thickness rotator cuff tear that's at least 2 cm wide. It must be their first repair, and they need an MRI from the last year.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Surgical Intervention
Participants undergo arthroscopic rotator cuff repair augmented with the FiberLocker® System
Post-operative Monitoring
Participants are monitored for healing and functional outcomes using MRI and various scoring systems
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- FiberLocker® System
Find a Clinic Near You
Who Is Running the Clinical Trial?
ZuriMED Technologies Inc.
Lead Sponsor